ALMOND- prunus dulcis injection, solution 
APPLE- malus domestica injection, solution 
APRICOT- prunus armeniaca injection, solution 
ASPARAGUS- asparagus officinalis injection, solution 
AVOCADO- persea americana injection, solution 
BANANA- musa sapientum injection, solution 
BARLEY- hordeum vulgare injection, solution 
BEEF- bos taurus injection, solution 
BELL PEPPER- capsicum annuum injection, solution 
BLACK PEPPER- piper nigrum injection, solution 
BRAZIL NUT- bertholletia excelsa injection, solution 
BROCCOLI- brassica oleracea var. botrytis injection, solution 
BUCKWHEAT- fagopyrum esculentum injection, solution 
CABBAGE- brassica oleracea var. capitata injection, solution 
CANTALOUPE- cucumis melo cantalupensis injection, solution 
CARROT- daucus carota injection, solution 
CASEIN- bos taurus injection, solution 
CELERY- apium graveolens injection, solution 
CHERRY- prunus avium injection, solution 
CHICKEN MEAT- gallus gallus injection, solution 
CINNAMON- cinnamomum verum injection, solution 
CLAM- mercenaria mercenaria injection, solution 
COCOA BEAN- theobroma cacao injection, solution 
COCONUT- cocos nucifera injection, solution 
CODFISH- gadus morhua injection, solution 
COFFEE- coffee arabica injection, solution 
COWS MILK- bos taurus injection, solution 
CRAB- paralithodes camtschaticus injection, solution 
CUCUMBER- cucumis sativus injection, solution 
EGG WHITE- gallus gallus injection, solution 
EGG YOLK- gallus gallus injection, solution 
EGG, WHOLE- gallus gallus injection, solution 
ENGLISH WALNUT- juglans regia injection, solution 
FLOUNDER- paralichthys dentatus injection, solution 
GARLIC- allium sativum injection, solution 
GOATS MILK- capra aegagrus hircus injection, solution 
GRAPEFRUIT- citrus x paradisi injection, solution 
GREEN PEA- pisum sativum injection, solution 
HALIBUT- hippoglossus hippoglossus injection, solution 
HONEYDEW- cucumis melo injection, solution 
KIDNEY BEAN- phaseolus vulgaris injection, solution 
LAMB- ovis aries injection, solution 
LEMON- citrus limon injection, solution 
LETTUCE- lactuca sativa injection, solution 
LIMA BEAN- phaseolus lunatus injection, solution 
LOBSTER- homarus americanus injection, solution 
MIXED FISH- paralichthys dentatus, gadus morhua, hippoglossus hippoglossus injection, solution 
MIXED SHELLFISH- paralithodes camtschaticus, crangon crangon, homarus americanus, crassostrea virginica injection, solution 
MUSHROOM- agaricus campestris injection, solution 
MUSTARD- sinapis alba injection, solution 
OAT GRAIN- avena sativa injection, solution 
OLIVE- olea europaea injection, solution 
ONION- allium cepa injection, solution 
ORANGE- citrus x sinensis injection, solution 
OYSTER- crassostrea virginica injection, solution 
PEACH- prunus persica injection, solution 
PEANUT- arachis hypogaea injection, solution 
PEAR- pyrus communis injection, solution 
PECAN NUT- carya illinoinensis injection, solution 
PINEAPPLE- ananas comosus injection, solution 
PISTACHIO NUT- pistacia vera injection, solution 
PLUM- prunus domestica injection, solution 
PORK- sus scrofa injection, solution 
RICE- oryza sativa injection, solution 
RYE GRAIN- secale cereale injection, solution 
SALMON- salmo salar injection, solution 
SESAME SEED- sesamum indicum injection, solution 
SHRIMP- crangon crangon injection, solution 
SOYBEAN- glycine max injection, solution 
SPINACH- spinacia oleracea injection, solution 
SQUASH- curcubita pepo injection, solution 
STRAWBERRY- fragaria x ananassa injection, solution 
STRINGBEAN- phaseolus vulgaris injection, solution 
SWEET CORN- zea mays injection, solution 
SWEET POTATO- ipomoea batatas injection, solution 
THEA SINENSIS- thea sinensis injection, solution 
TOMATO- solanum lycopersicum injection, solution 
TUNA- thunnus thynnus injection, solution 
TURKEY- meleagris gallopavo injection, solution 
VANILLA- vanilla planifolia injection, solution 
VITIS SPP- vitis spp injection, solution 
WATERMELON- citrullus lanatus injection, solution 
WHEAT GRAIN- triticum aestivum injection, solution 
WHITE POTATO- solanum tuberosum injection, solution 
ALK-Abello, Inc.
Reference Label Set Id: ae68305a-983c-43e8-abfb-169b90393340
Reference Label Set Id: 6e732f6a-636d-4099-be94-fd7d7af6ea70
Reference Label Set Id: 6ff47af6-ea2b-46a6-8d15-54bf1a46c26b
Reference Label Set Id: 56328113-0132-4e60-aa14-d3d373978f9c
Reference Label Set Id: ad2dbf12-46ff-45cc-b15f-daf1ecfc8718

----------

Food Allergenic Extracts

ALLERGENIC EXTRACTS,

FOR DIAGNOSTIC USE ONLY

DIRECTIONS FOR USE

WARNING

This product is intended for use by physicians who are experienced in the administration of allergenic extracts and the emergency care of anaphylaxis, or for use under the guidance of an allergy specialist.

As with all allergenic extracts, severe systemic reactions may occur. In certain individuals these life-threatening reactions may result in death. Fatalities associated with skin testing have been reported. Patients should be observed for at least 20 - 30 minutes following testing. Emergency measures and adequately trained personnel should be immediately available in the event of a life-threatening reaction.

Patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater risk to a fatal outcome from a systemic allergic reaction.

Sensitive patients may experience severe anaphlactic reactions resulting in respiratory obstruction, shock, coma and/or death. Adverse events are to be reported to MedWatch (1-800-FDA-1088), Adverse Event Reporting, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20852-9787. This product should not be injected intravenously. Patients receiving beta blockers may not be responsive to epinephrine or inhaled bronchodilators. Respiratory obstruction not responding to parenteral or inhaled bronchodilators may require theophylline, oxygen, intubation and the use of life support systems. Parenteral fluid and/or plasma expanders may be utilized for the treatment of shock. Adrenocorticosteroids may be administered parenterally or intravenously. Refer to WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections below.

Port Washington, NY 11050

U.S. Government License No. 1256

DESCRIPTION

Sterile diagnostic extracts are supplied in either phenol-saline diluent for Intradermal Testing or in diluent containing glycerin 50% (v/v) for Percutaneous Testing and phenol 0.4% (preservative). Inactive ingredients may include: sodium chloride for isotonicity, glycerin, and sodium bicarbonate as a bufferPollens are individually extracted from pure pollen extracted in a phenol-preserved sodium bicarbonate solution. Short Ragweed and Mixed (Tall and Short) Ragweed extracts are standardized by Antigen E content and so labeled. The Antigen E content of extracts containing Short Ragweed at a concentration more dilute than a weight/volume ratio of 1:10 are obtained by calculating the Antigen E content based on the assay value of more concentrated extract. Pollen extracts are filtered aseptically and after final packaging, they are tested for sterility and safety. Molds are individually extracted from pure powdered inactivated mold source material extracted in phenol preserved saline.Mold extracts are filtered aseptically and after final packaging are tested for sterility and safety.

Molds (fungi) are present in all inhabited places at all seasons of the year; they are so ubiquitous that they are prevalent at times when common allergic pollens and other inhalants are not. In the home and surroundings, molds are found in upholstered furniture, mattresses, drapes, cellar and storage room dust, woolens, leather goods, fruits, meats, cheeses, garden soil and on plants. Spores, mycelial fragments and mold residues are thus inhaled, contacted and ingested continuously.

Foods, miscellaneous inhalants and epidermals are individually extracted in phenol preserved saline or glycerin, filtered aseptically and after final packaging are tested for sterility and safety.

CLINICAL PHARMACOLOGY

Diagnostically (for skin testing) the allergen combines with IgE antibodies fixed to mast cells in the skin. This complexing causes an increase in cellular permeability and degranulation of the mast cells releasing chemical mediators. These mediators (such as histamine) are responsible for a local inflammatory response of wheal and erythema typical of a positive skin test reaction and also, the symptoms commonly associated with allergic disease.1 The more mediator release, the larger the reaction (wheal and erythema).

INDICATIONS AND USAGE

These products are for diagnostic use only. Diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. By measuring skin test response the physician may assess the degree of sensitivity that patients have to the allergens. For extracts standardized in AU and BAU, see individual directions for use. Allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use.

CONTRAINDICATIONS

Patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed WARNING statement and ADVERSE REACTIONS). The physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise.

Patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater risk to a fatal outcome from a systemic allergic reaction2,3. See also PRECAUTIONS and ADVERSE REACTIONS.

WARNING

Patients should always be observed for at least 20 - 30 minutes after skin testing. In the event of a marked systemic reaction such as urticaria, angioedema, wheezing, dyspnea, respiratory obstruction, hypotension, coma and death (see ADVERSE REACTIONS), applications of a tourniquet above the injection site and administration of 0.2 mL to 1 mL (0.01 mg/kg) of epinephrine injection (1:1,000) are recommended. Maximal recommended dose for children between 2 and 12 years of age is 0.5 mL. The tourniquet is then gradually released at 15 minute intervals. Patients under treatment with beta blockers may be refractory to the usual dose of epinephrine.

Volume expanders and vasopressor agents may be required to reverse hypotension, inhalation bronchodilators and parenteral aminophylline may be required to reverse bronchospasm. In case of respiratory obstruction, oxygen and intubation may be necessary. Life-threatening reactions unresponsive to the above may require cardiopulmonary resuscitation.

PRECAUTIONS

INFORMATION FOR PATIENTS:

Patients should be instructed to describe any active allergic symptoms such as rhinitis, wheezing, dyspnea, etc. prior to testing. Also, see ADVERSE REACTIONS and WARNINGS Sections.

Patients should always be observed 20 to 30 minutes after testing.

General:

  1. In the presence of active symptoms such as rhinitis, wheezing, dyspnea, etc., the indications for skin testing must be weighed carefully against the risk of temporarily aggravating the symptoms by the testing itself. Objective assessment of pulmonary function such as Peak Expiratory Flow Rate (PEFR) before allergen administration and prior to discharge may be useful in unstable asthmatics to reduce the chances of exacerbation of the patient’s asthma. Patients should be instructed to describe any active allergic symptoms as described above prior to skin testing and encouraged to report any late reactions from this testing. Also, see ADVERSE REACTIONS and WARNING sections.
  2. Store allergenic extracts between 2°-8°C at all times, even during use.
  3. Care must be taken to avoid drawing blood.
    1. For percutaneous testing, if blood is observed, immediately wipe the allergen from the site.
    2. For intradermal skin testing, pull gently on the syringe plunger and note if any blood enters the syringe. If blood is obtained, reposition the needle and repeat before injecting (see DOSAGE AND ADMINISTRATION).

  4. Allergenic extracts become less potent with age. Allergenic extracts containing glycerin 50% v/v are relatively stable. Non-glycerinated aqueous extracts, particularly dilute forms as used for intradermal skin testing, have been shown to be extremely unstable. Until such time as stability studies are complete with dilute allergens, new intradermal strength materials should be prepared every few weeks.
  5. Use standard aseptic precautions if making dilutions from stock concentrates to intradermal strength.
  6. For intradermal testing: Extracts in glycerin 50% v/v must be diluted with a non-glycerinated diluent and must be diluted at least 25-fold to less than 2% glycerin by volume, as glycerin above this level can cause false positive intradermal skin test results.

Pregnancy - Category C: 

Animal reproduction studies have not been conducted with allergenic extracts. It is also not known whether allergenic extracts can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.

Controlled studies of hyposensitization with moderate to high doses of allergenic extracts during conception and all trimesters of pregnancy have failed to demonstrate any risk to the fetus or to the mother4. However, on the basis of histamine’s known ability to contract the uterine muscle, the release of significant amounts of histamine from allergen exposure to skin test overdose should be avoided on theoretical grounds. Therefore, allergenic extracts should be used cautiously in a pregnant woman and only if clearly needed.

Pediatric Use:

Allergenic extracts for diagnostic use have been given safely in infants and young children. Infants have lower skin test reactivity to histamine, as well as common allergens. Skin test reactivity gradually increases to age 6 and plateaus to age 60. Therefore, small skin test reactions should be anticipated in children under age 6.

Geriatric Use: 

Skin test reactivity gradually decreases after age 60. Therefore, smaller skin test reactions should be anticipated in adults over age 60.

Nursing Mothers: 

It is not known if allergens administered subcutaneously appear in human milk. Because many drugs are excreted in human milk, caution should be exercised when allergenic extracts are administered to a nursing woman.

Carcinogenesis, mutagenesis, impairment of fertility: 

Studies in animals have not been performed.

Drug Interactions:

Drugs can interfere with the performance of skin tests5.

Antihistamines: Response to mediator (histamine) released by allergens is suppressed by antihistamines. The length of suppression varies and is dependent on individual patient, type of antihistamine and length of time the patient has been on antihistamines. The duration of this suppression may be as little as 24 hours (chlorpheniramine), and can be as long as 40 days (astemizole).

Tricyclic Antidepressants: These exert a potent and sustained decrease of skin reactivity to histamine which may last for a few weeks.

Beta2 Agonists: Oral terbutaline and parenteral ephedrine, in general, have been shown to decrease allergen induced wheal.

Dopamine: Intravenous infusion of dopamine may inhibit skin test responses.

Beta Blocking Agents: Propranolol can significantly increase skin test reactivity.

Other Drugs: Short acting steroids, inhaled beta2 agonists, theophylline and cromolyn do not seem to affect skin test response.

ADVERSE REACTIONS

Fatalities from skin testing in the United States have been extensively reviewed by Lockey.2 Six fatalities were associated with intradermal testing without previous percutaneous testing and one was associated with a combination of percutaneous (scratch) and intradermal skin testing. With careful attention to dosage and administration, fatal reactions occur infrequently, but it must be remembered that allergenic extracts are highly potent to sensitive individuals and overdosage could result in anaphylactic symptoms. Therefore it is imperative that physicians administering allergenic extracts for skin testing understand, and be prepared for the treatment of severe reactions.

Local:

Immediate wheal and erythema reactions are to be expected; but if very large, may be the first manifestation of a systemic reaction. In such cases, immediately wipe the test site(s) with sterile gauze or cotton to remove excess allergen.

Systemic Reactions: 

Systemic reactions are characterized by one or more of the following symptoms: sneezing, mild to severe generalized urticaria, itching (other than at the skin test site), extensive or generalized edema, wheezing, asthma, dyspnea, cyanosis, hypotension, syncope, and upper airway obstruction. Symptoms may progress to shock and death. Patients should always be observed for at least 20 - 30 minutes after testing.

Volume expanders and vasopressor agents may be required to reverse hypotension. Inhalational bronchodilators and parenteral aminophylline may be required to reverse bronchospasm. Severe airway obstruction unresponsive to bronchodilator may require tracheal intubation and use of oxygen. In the event of a marked systemic reaction, application of a tourniquet above the injection site and the administration of 0.2 mL to 1.0 mL of epinephrine injection (1:1,000) is recommended. Maximum recommended dose for children between 2 and 12 years of age is 0.3 mL. The tourniquet should not be left in place without loosening for 90 seconds every 15 minutes.

Adverse events should be reported via MedWatch (1-800-FDA-1088), Adverse Event Reporting, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20852-9787.

OVERDOSAGE

Signs and symptoms of overdose are typically large local and systemic reactions. For management of overdose reactions, refer to the ADVERSE REACTIONS section above.

DOSAGE AND ADMINISTRATION

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Skin test techniques for immediate (Type I) hypersensitivity testing fall into two major categories: percutaneous, and intracutaneous.

Percutaneous techniques:

For percutaneous testing, in general, skin is scratched, punctured or pricked just before the allergen is applied or through a drop of test allergen. There are several devices available for this technique. Refer to the manufacturer or distributor’s circular for specific directions for their use.

In General:

  1. It is recommended that the test areas should be placed no closer than 4 - 5 cm apart to avoid interference of reactions when several tests are applied.
  2. Skin test areas should be cleansed with alcohol and air dried.
  3. Preferably, the allergen should be placed on the volar surface of the forearm, upper arm, or the patient’s back. The patient should be placed in a comfortable position prior to testing.
  4. For scratch testing, a sharp, clean, sterile instrument is used to abrade the skin, but not to draw blood. Each scratch should be about 2 - 4 mm in length. A small drop of extract is placed on the surface of the skin.
  5. Prick testing: For prick testing, a sharp, sterile instrument is used to puncture the skin slightly, applying it at a 15 - 20° angle to the skin. The instrument is gently raised, “tenting” the skin until it pops out, generally pricking through the drop of allergen. Do not draw blood.
  6. For puncture testing, a sharp, clean, sterile instrument must be used. Puncture the skin, through the drop of allergen, perpendicular to the skin. Do not draw blood.

For all of the above techniques, a separate instrument must be used for each patient; if the instrument is to be used to pass through the allergen, to avoid cross-contamination, a separate instrument is to be used for each allergen. The test should be read in 15 minutes, measuring both wheal size and erythema.

Intracutaneous (intradermal) testing:

General: Intradermal testing is more sensitive than percutaneous testing and its specificity is dependent on dose. Intradermal testing is not intended as an initial screen unless used in highly dilute solutions. Intradermal testing is usually reserved for allergens that have demonstrated either negative or equivocal percutaneous skin test response in the face of positive or unclear history.

Intradermal testing of one allergen in several serial dilutions (beginning with the weakest to the more concentrated dilutions) may also be useful in assessing degree of patient sensitivity for the establishment of a safe starting dose for immunotherapy.

Bulk extracts must be diluted for intradermal testing. Use of Sterile Diluent for Allergenic Extracts or Sterile Diluent for Allergenic Extracts Normal Saline with HSA (albumin saline) is recommended. Dilutions should be made with sterile disposable syringes using aseptic technique. Commonly 10 fold dilutions are used to achieve a desired concentration for intradermal testing and continuation of immunotherapy. For example, transferring 0.5 mL of a 10,000 PNU/mL extract into 4.5 mL of diluent will yield 5 mL of extract at 1,000 PNU/mL. For weight volume products, a 1:100 w/v dilution may be prepared from a 1:10 w/v by transferring 0.5 mL of the 1:10 w/v to 4.5 mL of dilutent. Prepare as many additional serial dilutions as necessary to reach the appropriate concentration. As a general rule intradermal strength should begin at no higher than 1/100 to 1/1000 of the percutaneous strength that resulted in a negative skin test reaction.

  1. It is recommended that the test areas should be spaced no less than 5 cm apart to avoid interference with adjacent allergen or control.
  2. Skin should be cleansed with alcohol and air dried.
  3. A sterile 1 mL or 1/2 mL syringe with a 26 - 30 gauge needle should be used. A separate sterile syringe should be used for each extract and each patient.
  4. Care should be taken to eliminate air bubbles from the syringe prior to injecting the test dose. It is suggested that not more than 6 - 10 allergens of each different type be used at any one time. Very sensitive patients may show rapid response.
  5. The skin is held tensely, and the needle is inserted almost parallel to the skin, beveled side up far enough to cover the beveled portion. Slowly inject sufficient extract to make a small bleb of approximately 5 mm in diameter (0.01 - 0.02 mL).
  6. Read the test results in 15 minutes.

Selection of the proper strength for intracutaneous testing: A general rule for the prevention of untoward reactions, particularly in extremely sensitive patients, is to screen by percutaneous methods initially, and begin intradermal testing at a strength not more than 1/100 of a negative or equivocal percutaneous reaction.

Controls:

In both percutaneous and intracutaneous tests, a negative control test with diluent alone should be performed because some patients exhibit dermographia, and/or other non-specific irritant responses.

As a positive control in the evaluation of allergenic skin testing, histamine 1 mg/mL (histamine base) should be used for percutaneous testing, and histamine 0.1 mg/mL (histamine base) should be used for intradermal testing.

Interpretation of results:

Patient’s response is graded on the basis of the size of erythema or wheal.6 General guidelines follow for percutaneous testing, different devices and/or techniques influence the size of the reaction, therefore it is important to refer to the device manufacturer’s or distributor’s instructions when grading reactions.

Percutaneous (prick or scratch) test:

0       No reaction or less than control.

+       Erythema greater than control, smaller than a nickel (21 mm diameter).

++       Erythema greater than a nickel in diameter, no wheal.

+++ Wheal and erythema without pseudopods.

++++ Wheal and erythema with pseudopods.

Intradermal test:

0       No reaction or less than negative control.

+       3-4 mm wheal with erythema, or erythema alone larger than a nickel (21 mm diameter).

++       4-8 mm wheal and erythema, without pseudopods.

+++ Over 8 mm wheal and erythema without pseudopods.

++++ Wheal and erythema with pseudopods.

HOW SUPPLIED

For scratch and prick testing: 5 mL dropper applicator vials in 50% v/v glycerin or 10mL stoppered vial in 50% v/v glycerin. Available individually and in a complete set of the most common allergens. Available in either Protein Nitrogen Units (PNU/mL) or weight to volume (w/v).

For intracutaneous testing: 5 mL sterile vials, aqueous based, individually and in a complete set of the most common allergens. Available in either Protein Nitrogen Units (PNU/mL) or weight to volume (w/v).

Histatrol® Positive skin test control - histamine. 1 mg/mL and 0.1 mg/mL histamine base.

See Product Catalog for specific diagnostic concentrations available.

STORAGE

To maintain stability of allergenic extracts, proper storage conditions are essential. Bulk concentrates and diluted extracts are to be stored at 2º to 8ºC even during use. Bulk or diluted extracts are not to be frozen. Do not use after the expiration date shown on the vial label.

REFERENCES

  1. Holgate, S.T., Robinson, C. and Church, M.K. Mediators of immediate hypersensitivity. In Middleton et al: Allergy Principles and Practice, St. Louis, 1988, C.V. Mosby, p 135.
  2. Lockey, R.F., et al. Fatalities from immunotherapy (IT) and skin testing (ST). J. Allergy Clin. Immunol. 1987: 79: 660.
  3. Reid, M.J. et al. Survey of fatalities from skin testing and immunotherapy. 1985-1989. J. Allergy Clin Immunol. 1993; 92:6.
  4. DeBuske L. M. et al. Special problems regarding Allergen Immunotherapy in Immunology and Allergy Clinics of North America, Greenburger, P.A. Ed. February 1992; 145-149.
  5. Bousquet, J. In vivo methods for the study of allergy: skin test, techniques and interpretation. In: Middleton et al.: Allergy Principles and Practice 3rd Ed. St. Louis: CV Mosby, 1988:167.
  6. Freedman, S.O. Asthma and Allergic Rhinitis II. Clinical Aspects, in Freedman and Gold Clinical Immunology 2nd Ed. New York: Harper & Row, 1976: 131.

Revised  April 2017                   No. 112R      

© ALK-Abelló, Inc.

Distributed in Canada by:
ALK-Abelló Pharmaceuticals, Inc.
#35-151 Brunel Road
Mississauga, Ontario
Canada L4Z 2H6

PRINCIPAL DISPLAY PANEL

ALLERGENIC EXTRACT
DIN 00299987
5mL sterile multiple dose vial
FOR PERCUTANEOUS TESTING ONLY

PRINCIPAL DISPLAY PANEL
ALLERGENIC EXTRACT
DIN 00299987
5mL sterile multiple dose vial
FOR PERCUTANEOUS TESTING ONLY

PRINCIPAL DISPLAY PANEL

ALLERGENIC EXTRACT
DIN 00299987
10mL sterile multiple dose vial
FOR PERCUTANEOUS TESTING ONLY

PRINCIPAL DISPLAY PANEL
ALLERGENIC EXTRACT
DIN 00299987
10mL sterile multiple dose vial
FOR PERCUTANEOUS TESTING ONLY

ALMOND 
prunus dulcis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6100
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ALMOND (UNII: 3Z252A2K9G) (ALMOND - UNII:3Z252A2K9G) ALMOND0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6100-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6100-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
APPLE 
malus domestica injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6101
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
APPLE (UNII: B423VGH5S9) (APPLE - UNII:B423VGH5S9) APPLE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6101-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6101-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
APRICOT 
prunus armeniaca injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6102
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
APRICOT (UNII: 269CJD5GZ9) (APRICOT - UNII:269CJD5GZ9) APRICOT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6102-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6102-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
ASPARAGUS 
asparagus officinalis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6103
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ASPARAGUS (UNII: Z1EJP3037Z) (ASPARAGUS - UNII:Z1EJP3037Z) ASPARAGUS0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6103-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6103-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
AVOCADO 
persea americana injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6104
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOCADO (UNII: SDS87L369F) (AVOCADO - UNII:SDS87L369F) AVOCADO0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6104-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6104-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BANANA 
musa sapientum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6105
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BANANA (UNII: 4AJZ4765R9) (BANANA - UNII:4AJZ4765R9) BANANA0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6105-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6105-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BARLEY 
hordeum vulgare injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6106
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BARLEY (UNII: 5PWM7YLI7R) (BARLEY - UNII:5PWM7YLI7R) BARLEY0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6106-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6106-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BEEF 
bos taurus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6109
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BEEF (UNII: 4PIB2155QP) (BEEF - UNII:4PIB2155QP) BEEF0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6109-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6109-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BELL PEPPER 
capsicum annuum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6197
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GREEN BELL PEPPER (UNII: 4J4DOU3HEK) (GREEN BELL PEPPER - UNII:4J4DOU3HEK) GREEN BELL PEPPER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6197-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6197-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BLACK PEPPER 
piper nigrum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6198
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BLACK PEPPER (UNII: KM66971LVF) (BLACK PEPPER - UNII:KM66971LVF) BLACK PEPPER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6198-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6198-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BRAZIL NUT 
bertholletia excelsa injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6110
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BRAZIL NUT (UNII: XKR79OET1K) (BRAZIL NUT - UNII:XKR79OET1K) BRAZIL NUT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6110-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6110-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BROCCOLI 
brassica oleracea var. botrytis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6112
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BROCCOLI (UNII: UOI4FT57BZ) (BROCCOLI - UNII:UOI4FT57BZ) BROCCOLI0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6112-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6112-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
BUCKWHEAT 
fagopyrum esculentum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6113
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6113-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6113-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CABBAGE 
brassica oleracea var. capitata injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6114
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CABBAGE (UNII: GW0W1Y9I97) (CABBAGE - UNII:GW0W1Y9I97) CABBAGE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6114-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6114-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CANTALOUPE 
cucumis melo cantalupensis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6115
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CANTALOUPE (UNII: 8QF5D5H6UH) (CANTALOUPE - UNII:8QF5D5H6UH) CANTALOUPE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6115-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6115-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CARROT 
daucus carota injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6116
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CARROT (UNII: L56Z1JK48B) (CARROT - UNII:L56Z1JK48B) CARROT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6116-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6116-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CASEIN 
bos taurus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6118
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CASEIN (UNII: 48268V50D5) (CASEIN - UNII:48268V50D5) CASEIN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6118-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6118-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CELERY 
apium graveolens injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6120
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CELERY (UNII: 44IDY6DTKX) (CELERY - UNII:44IDY6DTKX) CELERY0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6120-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6120-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CHERRY 
prunus avium injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6121
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SWEET CHERRY (UNII: 93T4562ZI3) (SWEET CHERRY - UNII:93T4562ZI3) SWEET CHERRY0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6121-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6121-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CHICKEN MEAT 
gallus gallus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6122
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHICKEN (UNII: 0X8Q245Y7B) (CHICKEN - UNII:0X8Q245Y7B) CHICKEN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6122-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6122-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CINNAMON 
cinnamomum verum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6123
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CINNAMON (UNII: 5S29HWU6QB) (CINNAMON - UNII:5S29HWU6QB) CINNAMON0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6123-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6123-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CLAM 
mercenaria mercenaria injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6124
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NORTHERN QUAHOG (UNII: D6G49OV9IM) (NORTHERN QUAHOG - UNII:D6G49OV9IM) NORTHERN QUAHOG0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6124-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6124-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
COCOA BEAN 
theobroma cacao injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6125
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
COCOA (UNII: D9108TZ9KG) (COCOA - UNII:D9108TZ9KG) COCOA0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6125-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6125-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
COCONUT 
cocos nucifera injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6127
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
COCONUT (UNII: 3RT3536DHY) (COCONUT - UNII:3RT3536DHY) COCONUT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6127-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6127-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CODFISH 
gadus morhua injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6128
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6128-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6128-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
COFFEE 
coffee arabica injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6129
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ARABICA COFFEE BEAN (UNII: 3SW678MX72) (ARABICA COFFEE BEAN - UNII:3SW678MX72) ARABICA COFFEE BEAN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6129-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6129-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
COWS MILK 
bos taurus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6178
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SKIM MILK (UNII: 6A001Y4M5A) (SKIM MILK - UNII:6A001Y4M5A) SKIM MILK0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6178-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6178-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CRAB 
paralithodes camtschaticus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6130
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RED KING CRAB (UNII: E88KKF623O) (RED KING CRAB - UNII:E88KKF623O) RED KING CRAB0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6130-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6130-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
CUCUMBER 
cucumis sativus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6132
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CUCUMBER (UNII: YY7C30VXJT) (CUCUMBER - UNII:YY7C30VXJT) CUCUMBER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6132-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6132-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
EGG WHITE 
gallus gallus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6133
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
EGG WHITE (UNII: 3E0I92Z2GR) (EGG WHITE - UNII:3E0I92Z2GR) EGG WHITE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6133-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6133-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
EGG YOLK 
gallus gallus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6136
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
EGG YOLK (UNII: 4IPS17B70T) (EGG YOLK - UNII:4IPS17B70T) EGG YOLK0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6136-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6136-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
EGG, WHOLE 
gallus gallus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6135
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
EGG (UNII: 291P45F896) (EGG - UNII:291P45F896) EGG0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6135-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6135-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
ENGLISH WALNUT 
juglans regia injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6231
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ENGLISH WALNUT (UNII: 1V3SHR7QB7) (ENGLISH WALNUT - UNII:1V3SHR7QB7) ENGLISH WALNUT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6231-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6231-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
FLOUNDER 
paralichthys dentatus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6137
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SUMMER FLOUNDER (UNII: 50A63WC635) (SUMMER FLOUNDER - UNII:50A63WC635) SUMMER FLOUNDER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6137-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6137-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
GARLIC 
allium sativum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6138
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GARLIC (UNII: V1V998DC17) (GARLIC - UNII:V1V998DC17) GARLIC0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6138-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6138-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
GOATS MILK 
capra aegagrus hircus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6177
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GOAT MILK (UNII: XE5K5I4RP7) (GOAT MILK - UNII:XE5K5I4RP7) GOAT MILK0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6177-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6177-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
GRAPEFRUIT 
citrus x paradisi injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6141
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GRAPEFRUIT (UNII: O82C39RR8C) (GRAPEFRUIT - UNII:O82C39RR8C) GRAPEFRUIT0.10 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6141-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375301/01/1965
GREEN PEA 
pisum sativum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6191
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PEA (UNII: W4X7H8GYFM) (PEA - UNII:W4X7H8GYFM) PEA0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6191-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6191-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
HALIBUT 
hippoglossus hippoglossus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-7130
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-7130-065 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375301/01/1965
HALIBUT 
atlantic halibut injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6236
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6236-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375301/01/1965
HONEYDEW 
cucumis melo injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6146
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HONEYDEW MELON (UNII: RN8P45F92A) (HONEYDEW MELON - UNII:RN8P45F92A) HONEYDEW MELON0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6146-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6146-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
KIDNEY BEAN 
phaseolus vulgaris injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6107
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6107-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6107-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
LAMB 
ovis aries injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6149
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LAMB (UNII: FOF26T73HA) (LAMB - UNII:FOF26T73HA) LAMB0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6149-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6149-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
LEMON 
citrus limon injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6170
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LEMON (UNII: 24RS0A988O) (LEMON - UNII:24RS0A988O) LEMON0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6170-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6170-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
LETTUCE 
lactuca sativa injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6171
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LETTUCE (UNII: 5PO6NN3RRJ) (LETTUCE - UNII:5PO6NN3RRJ) LETTUCE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6171-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6171-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
LIMA BEAN 
phaseolus lunatus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6173
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIMA BEAN (UNII: 112YH1ZMX2) (LIMA BEAN - UNII:112YH1ZMX2) LIMA BEAN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6173-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6173-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
LOBSTER 
homarus americanus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6174
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AMERICAN LOBSTER (UNII: 6T362S6JF6) (AMERICAN LOBSTER - UNII:6T362S6JF6) AMERICAN LOBSTER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6174-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6174-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
MIXED FISH 
paralichthys dentatus, gadus morhua, hippoglossus hippoglossus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8043
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD0.1 g  in 1 mL
SUMMER FLOUNDER (UNII: 50A63WC635) (SUMMER FLOUNDER - UNII:50A63WC635) SUMMER FLOUNDER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-8043-065 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375301/01/1965
MIXED FISH 
paralichthys dentatus, gadus morhua, hippoglossus hippoglossus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8044
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ATLANTIC HALIBUT (UNII: 7E34E106BO) (ATLANTIC HALIBUT - UNII:7E34E106BO) ATLANTIC HALIBUT0.1 g  in 1 mL
ATLANTIC COD (UNII: RPX7J99EXW) (ATLANTIC COD - UNII:RPX7J99EXW) ATLANTIC COD0.1 g  in 1 mL
SUMMER FLOUNDER (UNII: 50A63WC635) (SUMMER FLOUNDER - UNII:50A63WC635) SUMMER FLOUNDER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-8044-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375301/01/1965
MIXED SHELLFISH 
paralithodes camtschaticus, crangon crangon, homarus americanus, crassostrea virginica injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8061
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RED KING CRAB (UNII: E88KKF623O) (RED KING CRAB - UNII:E88KKF623O) RED KING CRAB0.1 g  in 1 mL
COMMON SHRIMP (UNII: 1U601HV1HW) (COMMON SHRIMP - UNII:1U601HV1HW) COMMON SHRIMP0.1 g  in 1 mL
AMERICAN LOBSTER (UNII: 6T362S6JF6) (AMERICAN LOBSTER - UNII:6T362S6JF6) AMERICAN LOBSTER0.1 g  in 1 mL
EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-8061-065 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
MIXED SHELLFISH 
paralithodes camtschaticus, crangon crangon, homarus americanus, crassostrea virginica injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-8062
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RED KING CRAB (UNII: E88KKF623O) (RED KING CRAB - UNII:E88KKF623O) RED KING CRAB0.1 g  in 1 mL
COMMON SHRIMP (UNII: 1U601HV1HW) (COMMON SHRIMP - UNII:1U601HV1HW) COMMON SHRIMP0.1 g  in 1 mL
AMERICAN LOBSTER (UNII: 6T362S6JF6) (AMERICAN LOBSTER - UNII:6T362S6JF6) AMERICAN LOBSTER0.1 g  in 1 mL
EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-8062-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
MUSHROOM 
agaricus campestris injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6180
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CULTIVATED MUSHROOM (UNII: 54C8E6W6JY) (CULTIVATED MUSHROOM - UNII:54C8E6W6JY) CULTIVATED MUSHROOM0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6180-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6180-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
MUSTARD 
sinapis alba injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6181
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WHITE MUSTARD SEED (UNII: 25VR943RPP) (WHITE MUSTARD SEED - UNII:25VR943RPP) WHITE MUSTARD SEED0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6181-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6181-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
OAT GRAIN 
avena sativa injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6183
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVENA SATIVA WHOLE (UNII: 5P8D0Z74RG) (AVENA SATIVA WHOLE - UNII:5P8D0Z74RG) AVENA SATIVA WHOLE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6183-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6183-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
OLIVE 
olea europaea injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6185
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BLACK OLIVE (UNII: 2M6QWV94OC) (BLACK OLIVE - UNII:2M6QWV94OC) BLACK OLIVE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6185-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6185-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
ONION 
allium cepa injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6186
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ONION (UNII: 492225Q21H) (ONION - UNII:492225Q21H) ONION0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6186-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6186-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
ORANGE 
citrus x sinensis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6187
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ORANGE (UNII: 5EVU04N5QU) (ORANGE - UNII:5EVU04N5QU) ORANGE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6187-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6187-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
OYSTER 
crassostrea virginica injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6189
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
EASTERN OYSTER (UNII: 0I77C68AWS) (EASTERN OYSTER - UNII:0I77C68AWS) EASTERN OYSTER0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6189-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6189-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PEACH 
prunus persica injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6192
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PEACH (UNII: 3OKE88I3QG) (PEACH - UNII:3OKE88I3QG) PEACH0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6192-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6192-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PEANUT 
arachis hypogaea injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6193
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PEANUT (UNII: QE1QX6B99R) (PEANUT - UNII:QE1QX6B99R) PEANUT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6193-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6193-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PEAR 
pyrus communis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6195
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PEAR (UNII: 2ZN8DWC0YF) (PEAR - UNII:2ZN8DWC0YF) PEAR0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6195-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6195-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PECAN NUT 
carya illinoinensis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6196
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PECAN (UNII: F14P91GB5F) (PECAN - UNII:F14P91GB5F) PECAN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6196-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6196-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PINEAPPLE 
ananas comosus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6200
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PINEAPPLE (UNII: 2A88ZO081O) (PINEAPPLE - UNII:2A88ZO081O) PINEAPPLE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6200-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6200-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PISTACHIO NUT 
pistacia vera injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6202
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PISTACHIO (UNII: 6815CPT6ZJ) (PISTACHIO - UNII:6815CPT6ZJ) PISTACHIO0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6202-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6202-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PLUM 
prunus domestica injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6203
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PLUM (UNII: 67M3EQ6BE1) (PLUM - UNII:67M3EQ6BE1) PLUM0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6203-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6203-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
PORK 
sus scrofa injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6204
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PORK (UNII: O138UB266J) (PORK - UNII:O138UB266J) PORK0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6204-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6204-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
RICE 
oryza sativa injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6208
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WHITE RICE (UNII: A195V20H7A) (WHITE RICE - UNII:A195V20H7A) WHITE RICE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6208-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6208-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
RYE GRAIN 
secale cereale injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6210
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RYE (UNII: 0R4AQI398X) (RYE - UNII:0R4AQI398X) RYE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6210-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6210-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SALMON 
salmo salar injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6212
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ATLANTIC SALMON (UNII: 7062I37LB3) (ATLANTIC SALMON - UNII:7062I37LB3) ATLANTIC SALMON0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6212-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6212-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SESAME SEED 
sesamum indicum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6213
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SESAME SEED (UNII: 7Y1255HVXR) (SESAME SEED - UNII:7Y1255HVXR) SESAME SEED0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6213-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6213-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SHRIMP 
crangon crangon injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6214
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
COMMON SHRIMP (UNII: 1U601HV1HW) (COMMON SHRIMP - UNII:1U601HV1HW) COMMON SHRIMP0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6214-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6214-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SOYBEAN 
glycine max injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6216
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SOYBEAN (UNII: L7HT8F1ZOD) (SOYBEAN - UNII:L7HT8F1ZOD) SOYBEAN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6216-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6216-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SPINACH 
spinacia oleracea injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6218
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SPINACH (UNII: 6WO75C6WVB) (SPINACH - UNII:6WO75C6WVB) SPINACH0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6218-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6218-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SQUASH 
curcubita pepo injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6219
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZUCCHINI (UNII: EQU1BON34S) (ZUCCHINI - UNII:EQU1BON34S) ZUCCHINI0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6219-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6219-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
STRAWBERRY 
fragaria x ananassa injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6220
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
STRAWBERRY (UNII: 4J2TY8Y81V) (STRAWBERRY - UNII:4J2TY8Y81V) STRAWBERRY0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6220-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6220-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
STRINGBEAN 
phaseolus vulgaris injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6108
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
STRING BEAN (UNII: N9D69B2Q7Y) (STRING BEAN - UNII:N9D69B2Q7Y) STRING BEAN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6108-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6108-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SWEET CORN 
zea mays injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6221
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CORN (UNII: 0N8672707O) (CORN - UNII:0N8672707O) CORN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6221-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6221-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
SWEET POTATO 
ipomoea batatas injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6205
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SWEET POTATO (UNII: M9WGG9Z9GK) (SWEET POTATO - UNII:M9WGG9Z9GK) SWEET POTATO0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6205-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6205-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
THEA SINENSIS 
thea sinensis injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6235
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TEA LEAF (UNII: GH42T47V24) (TEA LEAF - UNII:GH42T47V24) TEA LEAF0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6235-065 mL in 1 VIAL; Type 0: Not a Combination Product
2NDC:0268-6235-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
TOMATO 
solanum lycopersicum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6224
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TOMATO (UNII: Z4KHF2C175) (TOMATO - UNII:Z4KHF2C175) TOMATO0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6224-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6224-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
TUNA 
thunnus thynnus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6226
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NORTHERN BLUEFIN TUNA (UNII: 816CLQ4017) (NORTHERN BLUEFIN TUNA - UNII:816CLQ4017) NORTHERN BLUEFIN TUNA0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6226-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6226-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
TURKEY 
meleagris gallopavo injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6229
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TURKEY (UNII: 8E9NT44R8I) (TURKEY - UNII:8E9NT44R8I) TURKEY0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6229-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6229-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
VANILLA 
vanilla planifolia injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6230
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
VANILLA BEAN (UNII: Q74T35078H) (VANILLA BEAN - UNII:Q74T35078H) VANILLA BEAN0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6230-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6230-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
VITIS SPP 
vitis spp injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6139
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GRAPE (UNII: 6X543N684K) (GRAPE - UNII:6X543N684K) GRAPE0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6139-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6139-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
WATERMELON 
citrullus lanatus injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6233
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATERMELON (UNII: 231473QB6R) (WATERMELON - UNII:231473QB6R) WATERMELON0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6233-1010 mL in 1 VIAL; Type 0: Not a Combination Product
2NDC:0268-6233-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
WHEAT GRAIN 
triticum aestivum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6234
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WHEAT (UNII: 4J2I0SN84Y) (WHEAT - UNII:4J2I0SN84Y) WHEAT0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6234-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6234-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
WHITE POTATO 
solanum tuberosum injection, solution
Product Information
Product TypeNON-STANDARDIZED ALLERGENICItem Code (Source)NDC:0268-6206
Route of AdministrationPERCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POTATO (UNII: CFE1S8DYWD) (POTATO - UNII:CFE1S8DYWD) POTATO0.1 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PHENOL (UNII: 339NCG44TV)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0268-6206-065 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0268-6206-1010 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA10375302/23/1998
Labeler - ALK-Abello, Inc. (809998847)

Revised: 12/2021
Document Id: f3ddff47-f7a4-470c-a8c7-59327c2fe099
Set id: 995bb426-9140-4ba8-b26f-4c8cf2efbae3
Version: 8
Effective Time: 20211208
 
ALK-Abello, Inc.